InfoBionic, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
InfoBionic, Inc. - overview
Established
2011
Location
Chelmsford, MA, US
Primary Industry
Medical Devices & Equipment
About
InfoBionic, Inc. , based in Chelmsford, Massachusetts, specializes in advanced remote cardiac monitoring solutions, offering AI-enabled technologies that enhance cardiac care through real-time data analysis and monitoring. Founded in 2011, InfoBionic, Inc. focuses on developing innovative remote cardiac monitoring solutions.
The company has attracted significant investment, notably raising USD 57. 765 mn in Series D funding on September 29, 2023, from investors including Mayo Clinic and Excel Venture Management. The firm operates from its headquarters in Chelmsford, US, and has completed a total of 11 deals to date. InfoBionic, Inc.
specializes in advanced remote cardiac monitoring solutions, with its flagship product, the MoMe ARC® platform. This system utilizes AI-enabled clinical workflows and high-quality ECG monitoring, offering configurable hospital-grade monitoring from various locations. The MoMe ARC® platform includes a range of biosensor lead sets for diverse patient needs, enhancing cardiac care through real-time data analysis. InfoBionic serves healthcare institutions, major hospitals, and specialized cardiac clinics across the United States, while also exploring international markets.
InfoBionic generates revenue primarily through partnerships and subscriptions to its MoMe ARC® monitoring service. Clients, including healthcare providers and institutions, utilize the AI-enabled technology for remote cardiac telemetry, with revenue generated from subscription fees and service agreements for installation, maintenance, and support. The company’s partnerships enhance the integration of its solutions into existing cardiac care protocols, improving patient outcomes and operational efficiencies. Following its most recent Series D funding round of USD 57.
765 mn in September 2023, InfoBionic plans to utilize these resources to support business expansion and promote the launch of its new MoMe® ARC system. The company aims to target new geographic markets and healthcare institutions, with specific plans for expansion into international regions to be announced in the near future.
Current Investors
Fort Point Angels, Tech Coast Angels, HealthTech Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Cardiology, Monitoring Equipment, Medical Software
Website
www.infobionic.com/
Verticals
Big Data, Cloud Computing, HealthTech, Manufacturing, Wearables & Quantified Self
Company Stage
Series D
Total Amount Raised
Subscriber access only
InfoBionic, Inc. - employee data
InfoBionic, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Member of the Board of Directors | BM | ||||||
| Board Member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.